NCT01522495View on ClinicalTrials.gov

Pilot Study to Determine Percent Tissue Perfusion and Cellular Viability Using SPY Imaging

NACompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Peripheral Vascular Disease
Interventions
DEVICE

SPY Imaging, ICG dye (0.2 - 0.5 mg/kg)

Intravenous(1X) in conjunction with SPY Imaging (1 arm)

DEVICE

SPY Imaging

SPY Imaging to assess tissue perfusion

Trial Locations (1)

20007

Georgetown University Medical Center; Center for Wound Healing, Washington D.C.

All Listed Sponsors
lead

Georgetown University

OTHER

NCT01522495 - Pilot Study to Determine Percent Tissue Perfusion and Cellular Viability Using SPY Imaging | Biotech Hunter | Biotech Hunter